Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Elexir Pharma AB

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 139,229 Less Arrow 108,935 Less Arrow 82,371
Financial expenses 0 More Arrow 11 More Arrow 49
Earnings before taxes 16,203 Less Arrow 12,407 Less Arrow 11,345
EBITDA 16,298 Less Arrow 12,541 Less Arrow 11,516
Total assets 62,704 Less Arrow 45,962 Less Arrow 33,095
Current assets 57,143 Less Arrow 42,385 Less Arrow 32,408
Current liabilities 21,777 Less Arrow 13,282 Less Arrow 9,091
Equity capital 39,507 Less Arrow 31,272 Less Arrow 23,043
- share capital 52 Less Arrow 51 Less Arrow 47
Employees (average) 19 Less Arrow 15 Less Arrow 10

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 63.0% More Arrow 68.0% More Arrow 69.6%
Turnover per employee 7,328 Less Arrow 7,262 More Arrow 8,237
Profit as a percentage of turnover 11.6% Less Arrow 11.4% More Arrow 13.8%
Return on assets (ROA) 25.8% More Arrow 27.0% More Arrow 34.4%
Current ratio 262.4% More Arrow 319.1% More Arrow 356.5%
Return on equity (ROE) 41.0% Less Arrow 39.7% More Arrow 49.2%
Change turnover 28,330 Less Arrow 20,720 Less Arrow 5,605
Change turnover % 26% Less Arrow 23% Less Arrow 7%
Chg. No. of employees 4 More Arrow 5 Less Arrow 0
Chg. No. of employees % 27% More Arrow 50% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.